A Randomized, Open-label, Single-dose, Three-way Crossover Study to Determine the Relative Pharmacokinetic Profile of Oral Doses of CONCERTA Tablets, Ritalin-SR Tablets and Novo-Methylphenidate ER-CTablets Under Fasted Condition in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2012
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- 08 Jul 2010 Actual number of patients added to 30 as reported by ClinicalTrials.gov.
- 08 Jul 2010 Actual initiation date changed to 1 May 2010 as reported by ClinicalTrials.gov.
- 08 Jul 2010 Actual end date added to 1 Jun 2010 as reported by ClinicalTrials.gov.